Cargando…

T-Cell Assay after COVID-19 Vaccination Could Be a Useful Tool? A Pilot Study on Interferon-Gamma Release Assay in Healthcare Workers

Background: SARS-CoV-2 T-cells are crucial for long-term protection against reinfection. The aim was to demonstrate the Interferon-gamma Release Assay (IGRA) test could be useful for vaccination monitoring. Methods: In a prospective cohort of 98 vaccinated healthcare workers for SARS-CoV-2, we selec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seraceni, Silva, Zocca, Elena, Cervone, Tamara Emanuela, Tomassetti, Flaminia, Polidori, Isabella, Valisi, Massimiliano, Broccolo, Francesco, Calugi, Graziella, Bernardini, Sergio, Pieri, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396988/ https://www.ncbi.nlm.nih.gov/pubmed/35997354 http://dx.doi.org/10.3390/diseases10030049

Ejemplares similares

Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers
por: Schipani, Maria Caterina, et al.
Publicado: (2022)

Characterization of Gut Microbiota Composition in Type 2 Diabetes Patients: A Population-Based Study
por: Polidori, Isabella, et al.
Publicado: (2022)

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
por: Infantino, Maria, et al.
Publicado: (2021)

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021)

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022)

Trends in Antibiotic Resistance of Nosocomial and Community-Acquired Infections in Italy
por: Cerini, Paola, et al.
Publicado: (2023)

Evaluation of ECLIA antigen detection tests as screening methods for COVID-19 in comparison with molecular analysis
por: Kolesova, Olga, et al.
Publicado: (2021)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark
por: Hermansen, Thomas Stig, et al.
Publicado: (2014)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis
por: Kim, Geon, et al.
Publicado: (2015)

Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
por: Stieber, Francis, et al.
Publicado: (2022)

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis
por: Ang, M, et al.
Publicado: (2012)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

The Usefulness of Interferon-gamma Release Assay for Diagnosis of Tuberculosis-related Uveitis in Korea
por: Ahn, Seong Joon, et al.
Publicado: (2014)

Diagnostic Performance of Interferon-Gamma Releasing Assay in HIV-Infected Patients in China
por: Yu, Yanhua, et al.
Publicado: (2013)

251 Interferon-Gamma Release Assay—Useful Tool for the Diagnosis of Pleural Tuberculosis
por: Ondrejkova, Andrea, et al.
Publicado: (2012)

Serial interferon-gamma release assays during treatment of active tuberculosis in young adults
por: Lee, Sei Won, et al.
Publicado: (2010)

TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays
por: Zwerling, Alice, et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance of Pleural Fluid and Peripheral Blood in Pleural Tuberculosis
por: Liu, Fei, et al.
Publicado: (2013)

Accuracy of the interferon-gamma release assay for the diagnosis of tuberculous pleurisy: an updated meta-analysis
por: Pang, Cai-Shuang, et al.
Publicado: (2015)

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays
por: Blount, Robert J., et al.
Publicado: (2016)

Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis
por: He, Xidong, et al.
Publicado: (2020)

Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
por: Scordo, Julia M., et al.
Publicado: (2021)

In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays
por: Osakabe, Yuki, et al.
Publicado: (2022)

Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection
por: Steindor, Mathis, et al.
Publicado: (2021)

Efficacy and Risk Factors of Interferon-Gamma Release Assays among HIV-Positive Individuals
por: Qin, Huifang, et al.
Publicado: (2023)

Diagnostic performance of interferon-Gamma assay for tuberculosis in immunocompromised patients
por: Su, Shih-Yang, et al.
Publicado: (2013)

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γ Release Assay-Positive Patients
por: Chen, Changguo, et al.
Publicado: (2017)

Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia
por: Adetifa, Ifedayo MO, et al.
Publicado: (2007)

The Role of the Interferon Gamma Release Assay in Assessing Recent Tuberculosis Transmission in a Hospital Incident
por: Bradshaw, Louise, et al.
Publicado: (2011)

Role of Interferon Gamma Release Assay in Active TB Diagnosis among HIV Infected Individuals
por: Syed Ahamed Kabeer, Basirudeen, et al.
Publicado: (2009)

Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection
por: Cattamanchi, Adithya, et al.
Publicado: (2010)

Evaluation of Interferon-Gamma Release Assays in the Diagnosis of Recent Tuberculosis Infection in Health Care Workers
por: Casas, Irma, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3eigmaa7n8nc228o7g54t3k6vf